Project info

  • Date: Sept 22, 2024
  • Client: AT & NLCF
  • Category:
  • Address: Rochdale, Manchester.UK

Project Details :

Prostate Cancer is the most common cancer in men in the UK and has no national screening programme. 1 in 8 men in the UK are likely to be diagnosed of prostate cancer in their life time and 12,000 men die of it every single year. More than 52,000 men are diagnosed every year in the UK

Crossway Alliance supported the development of the Prostate Cancer Awareness – a community initiative to promote awareness about the risk factors and symptoms. We collaborated with the other VCSFE’s to support a new community-focused effort to advance health equity and improve early cancer detection and management.

01

Community Awareness Campaign

Use of various channels to raise awareness- social media, events, providing educational materials and partnership with local organisations.
02

Targeted Outreach Programme

Focused on communities with high prostate cancer risk, Effective engagement using culturally sensitive messaging and outreach strategies and collaboration with VCSFE's.
03

Analysis and Monitoring Report

Analysis of project outcome ensuring it meets the objectives of our client. Use of feedback and lived experience information from participants , lessons learnt from the project to be used in improving future projects.

What We Did :

Collaboration with VCSFE's

As part of designing Prostate Cancer Awareness, a Public Health initiative, we:

Final Results :

We explored innovative ways that aims to increase awareness, early screening and early detection of prostate cancer through workshops using culturally sensitive, no jargons easy to read materials and use of interpreters where possible to eliminate language barrier.

Evidenced by the number of attendances, workshops held and referrals to primary care for prostate check. To date we present ourself as a trusted and committed partner with key partners and stakeholders in the borough and within the broader community as the company works towards reducing disparities in cancer screening.